A life of resilience: Kimberly Cowley's journey: Born with multiple health challenges, Kimberly overcame adversity through determination and advocacy, proving her detractors wrong and becoming an advocate for vaccinations
Despite facing numerous health challenges and adversities from a young age, Kimberly Cowley's story is one of resilience and determination. Born with congenital heart defects, hearing and vision loss, and the rare condition tetralogy of fallot, Kimberly's survival was considered a long shot. Her early life was filled with hospital stays and struggles in school due to her disabilities. Her parents, who were young and dealing with their own health issues, were unable to provide the necessary support and advocacy. Kimberly faced bullying and loneliness, but her will to live and prove her detractors wrong drove her to endure numerous heart surgeries and live a quiet, independent life. She uses various tools to navigate the world and has become an advocate for vaccinations, which could have saved her from her condition had they been available earlier. Kimberly's story is a reminder of the importance of advocacy, determination, and the power of the human spirit to overcome even the most significant challenges.
Discovering the Biology of Rubella Virus: Rubella is a single stranded positive RNA virus primarily transmitted via aerosols, causing systemic infection and Congenital Rubella Syndrome when contracted during pregnancy.
We discussed the biology of Rubella, a single stranded positive RNA virus that was recently reclassified from the Togaviridae family to the Metonaviridae family in the genus Arbovirus. Rubella is primarily transmitted via large particle aerosols and causes a systemic infection, spreading quickly throughout the body. It infects a wide range of cell types due to an unknown receptor on human cells. The virus is known for causing Congenital Rubella Syndrome when someone is infected during pregnancy, leading to major complications for the fetus. We also mentioned the availability of merchandise related to the podcast on the website, as well as resources for further reading on the topic. The episode delves deeper into the history and implications of Rubella, including its transmission, symptoms, and prevention methods. Stay tuned for more fascinating insights on this topic and others.
Rubella primarily affects humans, causing mild symptoms and rare complications, except for congenital rubella syndrome in pregnant women: Rubella is a virus that can cause mild symptoms in humans, but if a pregnant woman contracts it during the first trimester, it can lead to severe birth defects known as congenital rubella syndrome
Rubella, or German Measles, is a virus that can infect various cell types and cause damage by directly killing infected cells. However, it primarily affects humans and is usually associated with mild, self-limited symptoms, including a rash that starts on the face and spreads quickly. The illness is often milder in children than adults, and while complications like arthralgias, encephalitis, and congenital rubella syndrome are possible, they are rare. The most significant impact of Rubella is the risk of congenital rubella syndrome when a pregnant woman contracts the virus for the first time during the first trimester, leading to various birth defects in the developing fetus.
Rubella's Impact on Fetal Development: Rubella inhibits fetal cell growth and division, causing potential developmental issues. Transmitted through multiple bodily fluids, it interacts with the underdeveloped immune system, leading to chronic infection and severe downstream effects, including heart defects and organ development issues.
Rubella, a virus that can infect a pregnant person, has significant effects on a developing fetus during the embryonic stage, even before it becomes a fetus. Unlike in grown adults where rubella causes symptoms through direct cell death, in a fetus, the virus inhibits cell growth and division, leading to a reduction in cell mass and potential developmental issues. Rubella can infect various cells, and it's transmitted through multiple bodily fluids, not just respiratory. In the fetus, rubella is a chronic infection, and its interaction with the underdeveloped immune system adds to the complexity of the effects. Additionally, when rubella infects the endothelial cells of the blood vessels in a developing fetus, it can cause severe downstream effects, including heart defects and developmental issues in various organs.
Timing of a mother's rubella infection during pregnancy impacts fetus: First trimester infections cause severe fetal issues, while later infections have minimal impact, but can still lead to late-onset problems and complications.
The timing of a mother's rubella infection during pregnancy significantly impacts the severity and long-term effects on the fetus. Infections during the first 12 weeks almost always result in fetal malformations or problems, while infections after 16-18 weeks have minimal downstream effects. The virus can affect various parts of the fetus, leading to transient manifestations (such as jaundice, hepatitis, and a blueberry muffin rash) or permanent manifestations (like deafness). There are also late-onset problems that may not be detectable at birth but become apparent later in life. It's important to note that these infants can be very sick, and while transient manifestations tend to clear on their own, they often come with additional complications. Early infections can also result in pregnancy loss, but the exact proportion of this outcome is unknown.
Causes and Effects of Congenital Rubella Syndrome: Two-thirds of babies with Congenital Rubella Syndrome experience hearing loss, half have heart defects, and a quarter develop vision problems. The vaccine for rubella provides immunity in 95% of people and lasts up to 21 years, but the virus persists due to its contagious nature and need for consistent vaccination coverage.
Congenital Rubella Syndrome (CRS) can cause a range of health issues, primarily affecting the ears, heart, and vision. Approximately two-thirds of babies born with CRS experience hearing loss, while around half have heart defects. A quarter of these babies develop cataracts or other vision problems. These complications can occur during organ development or from tissue damage and scarring. Long-term or delayed manifestations include conditions like type 1 diabetes, thyroid dysfunction, and vascular problems. The vaccine for rubella, a live attenuated virus, provides immunity in 95% of people and lasts up to 21 years. The origins of the rubella virus are uncertain, but it's believed to have originated in Asia. Despite the availability of the vaccine, the virus persists due to its contagious nature and the need for consistent vaccination coverage.
Newly discovered viruses related to rubella in mammals: Recent discoveries of Rohugavirus and Russelavirus in mammals raise concerns about potential zoonotic spillover events and offer opportunities for comparative studies to better understand rubella's impacts on the body and fetus. The history of rubella's classification as a separate disease was a long and debated process.
Recent discoveries have revealed the existence of two new viruses, Rohugavirus and Russelavirus, which are closely related to rubella. These viruses were found in various mammal species, raising concerns about potential zoonotic spillover events. The new findings also offer opportunities for comparative studies and exploring different animal models to better understand the wide-ranging impacts of the rubella virus on the body and the fetus. Looking back in history, the debate over whether rubella was a distinct disease or just a variant of measles or scarlet fever was ongoing until the 18th century. The name "German measles" was popularly used, but it is not the name we use today. It wasn't until the 19th century that rubella was widely accepted as a separate disease, despite early descriptions and research. Despite the progress made, hesitancy to accept rubella as a separate disease persisted within the medical community.
Proposing the name 'rubella' for German measles: The name of a disease influences its understanding and identification. Rubella was proposed in 1866 and eventually replaced 'German measles' due to historical context and medical advancements.
The name of a disease plays an essential role in its identification and understanding. In 1866, a British Royal Artillery Surgeon proposed the name "rubella" for the disease previously known as rutum or German measles. Although the term "German measles" persisted due to confusion and anti-German sentiment during World Wars 1 and 2, the proposal of "rubella" eventually caught on. The early 20th century saw significant advancements in medicine, including the shift from qualitative descriptions to scientific observation and measurement. This period also marked the development of specialized fields in medicine, making it possible to identify and address diseases more effectively. Despite the fear and impact of diseases like tuberculosis and polio, the mildness of rubella at the time made it a low priority for research and development of a vaccine. However, the importance of disease nomenclature highlights the evolving understanding of health and medicine throughout history.
Discovering the link between rubella and congenital abnormalities: Pediatric ophthalmologist Norman McAllister Greg identified the connection between rubella during pregnancy and congenital abnormalities in 1941, thanks to mothers' observations and his unique perspective as a clinician-researcher.
The connection between a rubella infection during pregnancy and congenital abnormalities was first identified by Australian pediatric ophthalmologist, Norman McAllister Greg, in 1941. This discovery was significant because at the time, the idea of an infectious disease affecting a fetus had not been considered, and the link was initially suggested by mothers in the waiting room of Greg's clinic. Greg's unique perspective as both a clinician and a researcher allowed him to investigate this phenomenon further and make the connection. The historical context of the time, including the ongoing World War 2 and the increasing specialization in medicine, also played a role in enabling this discovery. Greg's willingness to listen to his patients and consider their hypotheses led to the identification of congenital rubella syndrome, which has since been linked to a range of health issues beyond just eye problems.
Rubella during WW2 caused increase in congenital defects: During WW2, rubella caused many congenital defects due to its difficulty to diagnose and high rate of asymptomatic infections. Awareness and prevention efforts led to the development of a vaccine.
During World War II, the movement of troops led to widespread rubella epidemics, causing an increase in congenital rubella cases. The diagnosis of rubella was difficult due to its similarities with other diseases and the high rate of asymptomatic infections. Doctor Greg's hypothesis linking rubella to congenital defects was met with skepticism initially, but as more data emerged, the link became more accepted. The discovery of the dangers of rubella during pregnancy raised awareness and led to efforts to minimize the risk of infection, including public education and prophylaxis, before the development of a vaccine.
Societal response to Rubella epidemics in the 1960s: Lack of knowledge, resources, and empathy during Rubella epidemics led to societal stigma, media framing of children with CRS as a social problem, and institutionalization.
During the rubella epidemics in the 1960s, the societal response was shaped by a lack of knowledge, resources, and empathy. The media framed children with Congenital Rubella Syndrome (CRS) as a social problem due to the overwhelming strain on institutions and families. This was a time when society lacked the knowledge and resources to adequately care for people with disabilities, often leading to institutionalization. The social stigma and shame associated with having a child with congenital defects also compounded the issue. The media attention reached new heights during the 1963-1965 epidemic due to the fresh memories of polio and the Thalidomide scandal, which put the fear of birth defects into the public consciousness. Approximately 12.5 million people were infected, and around 20,000 babies were born with CRS, causing immense stress and emotional turmoil for families. The societal response serves as a reminder of the importance of empathy, knowledge, and resources in addressing public health crises.
Thalidomide and Rubella: Shifting the Narrative Around Abortion: The thalidomide scandal and rubella epidemic led to increased focus on informed consent and women's rights, ultimately resulting in legal protections for a woman's right to access information about her health and make decisions about her pregnancy.
The combination of the thalidomide scandal and the rubella epidemic in the early 1960s played a significant role in shifting the narrative around abortion from one of secrecy and illegality to one of informed choice and women's rights. During this time, seeking an abortion was often a dangerous and stigmatized experience, with women facing moral judgment and even criminal charges. However, the public discussions surrounding thalidomide and rubella brought attention to the importance of informed consent and the right to make personal health decisions. This led to legal battles and the eventual passing of laws that protected a woman's right to access information about her own health and to make decisions about her pregnancy. Unfortunately, this progress was not evenly applied to all communities, and people of color continued to face discrimination and bias in the medical system. Overall, these events marked a turning point in the history of abortion in the US, paving the way for more open and inclusive discussions and policies.
Successful Rubella Vaccination Campaigns: The development and implementation of the rubella vaccine led to a dramatic decrease in rubella cases in the US, and global vaccination coverage has increased significantly over the past 20 years, resulting in a 97% decrease in reported cases.
The development and implementation of the rubella vaccine in the late 1960s and 1970s led to one of the most successful vaccination campaigns in history, resulting in a dramatic decrease in rubella cases and the elimination of the disease in the US by 2004. Over the past 20 years, the global vaccination coverage for rubella has significantly increased, leading to a 97% decrease in reported rubella cases, despite challenges such as lapsed vaccination rates and lack of access to vaccinations in some areas. This progress is a testament to the importance of vaccines in preventing infectious diseases and improving public health.
Rubella Cases on the Rise Despite Elimination Efforts: Despite progress towards eliminating rubella and measles, increasing cases and ongoing transmission in some regions highlight the importance of continued vaccination campaigns and access to vaccines.
The number of reported rubella cases has increased in recent years, with 71% of countries conducting surveillance and reporting to the World Health Organization. However, the goal of eliminating measles and rubella by 2020, set by the World Health Organization, has not been achieved yet. The Americas were declared free of endemic rubella in 2015, but some countries in the region have experienced endemic transmission of measles, which could potentially lead to rubella outbreaks. The focus is on vaccination campaigns and ensuring every child has access to the rubella vaccine. The status of rubella is a reminder of the importance of continued efforts to eliminate these diseases. Sources include academic papers, books, and reports from organizations like the World Health Organization.
Emphasizing the importance of hand washing: Regular hand washing is a simple yet powerful habit that significantly impacts public health by preventing the spread of diseases.
Maintaining good hygiene, specifically washing your hands, is crucial in preventing the spread of diseases. This was emphasized during our discussion. It's a simple yet powerful habit that can make a significant impact on public health. Despite the importance of this practice, it's surprising how often it's overlooked. So, remember to wash your hands regularly to keep yourself and those around you healthy. It's a small act with a big impact. Let's all do our part in promoting good hygiene and keeping our communities healthy. Until next time, stay clean and stay safe!
Ep 64 Rubella: Timing is Everything
Recent Episodes from This Podcast Will Kill You
Special Episode: Dan Egan & The Devil’s Element
Ep 151 Stethoscope: Lub dub
Ep 150 Norovirus: Tip of the poop iceberg
Special Episode: Maria Smilios & The Black Angels
Ep 149 Poison Control Part 2: Call me maybe
Ep 148 Poison Control Part 1: Who you gonna call?
Special Episode: Ben Goldfarb & Crossings
Ep 147 Tasmanian Devil Facial Tumor Disease: Sympathy for the Devil
Ep 146 Celiac Disease: Rootin tootin gluten
Special Episode: Dr. Rageshri Dhairyawan & Unheard
Related Episodes
[BEST OF] Robots In My Head: Deep Brain Stimulation (EP298 Rerun)
Mental health is an umbrella term that spans a spectrum of severity. But when it comes to treatment-resistant major depressive disorder, it's a whole other ball game. A former healthcare communications executive, Jon Nelson is a living, breathing example of hope and progress in the mental health ecosystem. Joining Jon is Dr. Helen Mayberg, a neurologist, and psychiatrist at the Nash Family Center for Advanced Circuit Therapeutics. Learn how the latest advances in Deep brain stimulation (DBS) practically cure suicidal patients like Jon, but not without a considerable asterisk around access, approval loopholes, coverage, emerging skepticism, and, of course, massive stigma.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Fight Cancer! with The American Cancer Society Cancer Action Network
Today's episode is made possible in part by The American Cancer Society Cancer Action Network (ACS CAN,) the nation's leading cancer advocacy organization that is working every day to make cancer issues a national priority.
Today I am joined live in-studio by Pam Traxel (ACS CAN Senior Vice President for Alliance Development and Philanthropy), Kate Weissman, a young adult cervical cancer survivor, and Ian Locke, a Ph.D. student in molecular cancer biology at Duke University.
Kate is a state lead ambassador for ACS CAN in Massachusetts, and Ian is a congressional district member for ACS CAN in North Carolina. Together with Pam, we talk about channeling anger into action, what lobbying the federal government looks like, and how getting legislation passed across the aisle can help millions of Americans at a clip.
What's more, we invite you — the listener — to join the thousands of cancer patients, survivors, caregivers, and advocates fighting every day on Capitol Hill to make healthcare suck less for Americans. Why complain when you can do something tangible right now? How would you like to help reduce drug costs, improve access to care, and motivate the FDA to approve new life-saving treatments?
Visit https://fightcancer.org/pod and see how you can take an active role in influencing the government to do the right thing and help cancer patients around the country.
That's https://www.fightcancer.org/pod
Now go and be a badass cancer advocate.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
When The Doctor Gets The Cancer: Dr. Beverly Zavaleta
Beverly A. Zavaleta, MD, is a board-certified family physician, cancer survivor, and long-time advocate of patient education. The author of "Braving Chemo: What to Expect, How to Prepare, and How to Get Through It," Beverly talks about the "good problem to have" of being a medical professional and a cancer patient simultaneously. An unapologetic straight-shooter, she and Matthew hit all the nerves, especially the GenX nostalgia factor. Learn more about Beverly, her book, and her work at https://www.beverlyzavaletamd.com.
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.